Ignite Creation Date:
2024-05-06 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05096390
Status:
RECRUITING
Last Update Posted:
2024-01-25
First Post:
2021-10-14
Brief Title:
Axitinib - Pembrolizumab in First Line Treatment of mPRCC
Sponsor:
Centre Leon Berard
Organization:
Centre Leon Berard
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Papillary Renal Cell Carcinoma Type 2 |
Keywords:
| Name | View |
|---|---|
| PRCC | View |